Cogent Biosciences, Inc. (COGT)
NASDAQ: COGT · Real-Time Price · USD
10.98
+0.13 (1.20%)
At close: Jul 11, 2025, 4:00 PM
11.06
+0.08 (0.73%)
After-hours: Jul 11, 2025, 7:59 PM EDT
Cogent Biosciences Market Cap
Cogent Biosciences has a market cap or net worth of $1.53 billion as of July 11, 2025. Its market cap has increased by 68.36% in one year.
Market Cap
1.53B
Enterprise Value
1.30B
1-Year Change
68.36%
Ranking
Category
Stock Price
$10.98
Market Cap Chart
Since July 10, 2020, Cogent Biosciences's market cap has increased from $124.27M to $1.53B, an increase of 1,132.46%. That is a compound annual growth rate of 65.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 11, 2025 | 1.53B | 77.76% |
| Dec 31, 2024 | 861.60M | 70.14% |
| Dec 29, 2023 | 506.41M | -37.32% |
| Dec 30, 2022 | 807.97M | 136.30% |
| Dec 31, 2021 | 341.92M | -2.42% |
| Dec 31, 2020 | 350.40M | 181.97% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 711.91B |
| Johnson & Johnson | 377.51B |
| AbbVie | 339.94B |
| Novo Nordisk | 305.41B |
| UnitedHealth Group | 275.86B |
| Novartis AG | 236.71B |
| Abbott Laboratories | 229.69B |
| AstraZeneca | 218.74B |